Principles and practices in the management of obesity

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 3, 2003, Pages 274-280

  Foster, Gary D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENFLURAMINE; OBERMINE; PHENTERMINE; PHENTERMINE RESIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ANOREXIA NERVOSA; BEHAVIOR; BODY WEIGHT; CLINICAL PRACTICE; CONSTIPATION; DEFECATION; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; ENERGY BALANCE; FECES INCONTINENCE; FLATULENCE; GENERAL PRACTITIONER; GOOD GENERAL CONDITION; HEALTH CARE SYSTEM; HEART PALPITATION; HUMAN; HYPERTENSION; INSOMNIA; MEDICAL ASSESSMENT; NAUSEA; NOTE; OBESITY; PHYSICAL ACTIVITY; PHYSICIAN; PRIORITY JOURNAL; PSYCHOTHERAPY; SLEEP APNEA SYNDROME; VERTIGO; WEIGHT REDUCTION; XEROSTOMIA;

HUMANS; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE;

EID: 0041621789     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200205-456PP     Document Type: Note

References (77)

1. Young TY, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
2. Strohl KP, Strobel RJ, Parisi RA. Obesity and pulmonary function. In: Bray GA, Bouchard C, James WPT, editors. Handbook of obesity. New York: Marcel Dekker; 1998. p. 725-739.
3. Peppard P, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-3021.
4. Smith PL, Gold AR, Meyers D, Haponi EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985;103:850-855.
5. Barvaux VA, Aubert G, Rodenstein DO. Weight loss as a treatment for obstructive sleep apnea. Sleep Med Rev 2000;4:435-452.
6. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep 1996;19:104-115.
7. Flemons WW. Obstructive sleep apnea. N Engl J Med 2002;347:498-504.
8. Kushner RF. Obesity management for obstructive sleep apnea. In: Fairbanks D, Mickelson F, Woodon T, editors. Snoring and obstructive sleep apnea. Philadelphia: Lippincott, Williams & Wilkins; 2002.
9. Pack AI. Issues in sleep and breathing. Sleep Med Rev 2000;4:407-409.
10. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289:187-193.
11. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638.
12. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report: National Institutes of Health. Obes Res 1998;6:51S-210S.
13. Field AE, Barnoya J, Colditz GA. Epidemiology and health and economic consequences of obesity. In: Wadden TA, Stunkard AJ, editors. Handbook of obesity treatment. New York: Guilford Press; 2002. p. 3-18.
14. Wadden TA, Womble LG, Stunkard AJ, Anderson DA. Psychosocial consequences of obesity and weight loss. In: Wadden TA, Stunkard AJ, editors. Handbook of obesity treatment. New York: Guilford Press; 2002. p. 144-169.
15. Kushner R, Foster GD. Obesity and quality of life. Nutrition 2000;16:947-952.
16. Flegal K, Carroll M, Ogden C, Johnson C. Prevalence and trends in obesity among US Adults. 1999. JAMA 2002;288:1723-1727.
17. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 1998;22:39-47.
18. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002;288:1758-1761.
19. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization; 1998.
20. U.S. Department of Health and Human Services. Surgeon General's call to action to prevent and decrease overweight and obesity. Washington. DC: U.S. Government Printing Office; 2001.
21. Metropolitan Life Insurance Company. Metropolitan height and weight standards. Star Bull Metropol Life Insur Co 1983;64:2-9.
22. Harrison GG. Height-weight tables. Ann Intern Med 1985;103:989-994.
23. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalhoff RK, Adams PW. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-260.
24. Lapidus L, Bengtsson B, Larsson B, Pennert K, Rybo E, Sjostrom D. Distribtion of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984;289:1261-1263.
25. Millman RP, Carlisle CC, McGarvey ST, Eveloff SE, Levinson PD. Body fat distribution and sleep apnea severity in women. Chest 1995;107:362-366.
26. Grunstein R, Wilcox I, Yang T, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes 1993;17:533-540.
27. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158.
28. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T, Kotani K, Nakamura T, Takemura K, Matsuzawa Y. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997;241:11-18.
29. NHLBI. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. 2000 NIH Publication No. 00-4084. http://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf.
30. Korner J, Aronne LJ. The emerging science of body weight regulation and its impact on obesity treatment. J Clin Invest 2003;111:565-570.
31. Nielson SJ, Popkin BM. Patterns and trends in food portion sizes, 1977-1978. JAMA 2003;289:450-453.
32. Foster GD, Phelan S. Environmental challenges and assessment. In: Berndanier C. editor. The handbook of nutrition and food. Boca Raton: CRC Press; 2001. p. 773-785.
33. Segal NL, Allison DB. Twins and virtual twins: bases of relative body weight revisited. Int J Obes Relat Metab Disord 2001;9:257-263.
34. Comuzzie AJ. The genetic contribution to human obesity: the dissection of a complex phenotype. In: Johnston FE, Foster GD, editors. Obesity, growth and development. London: Smith-Gordon; 2001. p. 21-36.
35. Chagnon YC, Rankinen T, Snyder EE, Weisnagel SJ, Pérusse L, Bouchard C. The human obesity gene map: the 2002 update. Obes Res 2003;11:313-367.
36. Golay A, Allaz AF, Morel Y, de Tonnac N, Tankova S, Reaven GM. Similar weight loss with low- or high-carbohydrate diets. Am J Clin Nutr 1996;63:174-178.
37. Freedman MR, King J, Kennedy E. Popular diets: a scientific review. Obes Res 2001;9:1S-40S.
38. Bravata DM, Sanders L, Huang J, Krunholz HM, Ingram O, Gardner CD, Bravata DM. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003;289:1837-1850.
39. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
40. Brehm BJ, Seeley RJ, Daniels SR, D'Alessio DA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab 2003;88:1617-1623.
41. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. A multi-center, randomized, controlled trial of a low-carbohydrate diet for obesity. N Engl J Med 2003;348:2082-2090.
42. Samaha FF, Iqbal N, Seshradi P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ, Stern L. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 2003;348:2074-2081.
43. Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am 2000;84:441-461.
44. Brownell KD. The LEARN program for weight management 2000. Dallas: American Health Publishing Co.; 2000.
45. Dubbert PM, Wilson GT. Goal-setting and spouse involvement in the treatment of obesity. Behav Res Ther 1984;22:227-242.
46. Boutelle KN, Kirschenbaum DS. Further support for consistent self-monitoring as a vital component of successful weight control. Obes Res 1998;6:219-224.
47. Perri MG, McAllister DA, Gange JJ, Jordan RC, McAdoo WG, Nezu AM. Effects of four maintenance programs on the long-term management of obesity. J Consult Clin Psychol 1988;56:529-534.
48. Perri MG, Corsica JA. Improving the maintenance of weight lost in behavioral treatment of obesity. In: Wadden TA, Stunkard AJ, editors. Handbook of obesity treatment. New York: Guilford Press; 2002. p. 357-379.
49. Kayman S, Bruvold W, Stern JS. Maintenance and relapse after weight loss in women: behavioral aspects. Am J Clin Nutr 1990;52:800-807.
50. Wadden TA, Vogt RA, Foster GD, Anderson DA. Exercise and the maintenance of weight loss: one-year follow-up of a controlled clinical trial. J Consult Clin Psychol 1998;66:429-433.
51. The global pharmaceutical market: a detailed look at 2002. London: Intercontinental Medical Statistics Health; 2003.
52. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 2002;346:591-602.
53. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 1998;6:1-11.
54. James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomized trial: sibutramine trial of obesity reduction and maintenance. Lancet 2000;356:2119-2125.
55. Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HPF, Krempf M, European Multicenter Orlistat Study Group. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-172.
56. Cavaliere H, Floriano I, Medeiros-Neto G. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int J Obes 2001;25:1095-1099.
57. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 2001;161:218-227.
58. Sugerman HJ. Obesity surgery. Surg Clin North Am 2001;81:1001-1198.
59. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 2002;288:2793-2796.
60. Sugerman HJ, Londrey GL, Kellum JM. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass with selective vs. random assignment. Am J Surg 1989;157:93-102.
61. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-352.
62. Schauer PR, Ikramuddin S. Laparoscopic surgery for morbid obesity. Surg Clin North Am 2001;81:1145-1180.
63. Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ, Wolfe BM. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279-289.
64. Wadden TA, Sarwer DB, Womble LG, Foster GD, McGuckin BG, Schimmel A. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001;81:1001-1024.
65. Klein S. Medical management of obesity. Surg Clin North Am 2001;81:1025-1038.
66. Frank A. Futility and avoidance: medical professionals in the treatment of obesity. JAMA 1993;269:2132-2133.
67. Foster GD, Wadden TA, Makris AP, Davidson D, Swain Sanderson R, Allison DB, Kessler A. Primary care physicians' attitudes about obesity and its treatment. Obes Res (In press)
68. Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer FX. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003;289:1792-1798.
69. Stunkard AJ, Sobal J. Psychosocial consequences of obesity. In: Brownell KD, Fairburn CG, editors. Eating disorders and obesity. New York: Guilford Press; 1995. p. 417-421.
70. Price JH, Desmond SM, Krol RA, Snyder FF, O'Connell JK. Family practice physicians' beliefs, attitudes and practices regarding obesity. Am J Prev Med 1987;3:215-220.
71. Foster GD, Johnson C. Facilitating health and self-esteem among obese patients. Primary Psychiatry 1998;5:89-95.
72. Stunkard AJ. Talking with patients. In: Stunkard AJ, Wadden TA, editors. Obesity: theory and therapy. New York: Raven Press; 1993. p. 355-363.
73. Foster GD. Goals and strategies to improve behavior-change effectiveness. In: Bessesen DH, Kushner RF, editors. Evaluation and management of obesity. Philadelphia: Hanley & Belfus; 2002. p. 29-32.
74. Wadden TA, Berkowitz RI, Vogt RA, Steen SN, Stunkard AJ, Foster GD. Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach. Obes Res 1997;5:218-226.
75. Foster GD, Wadden TA, Phelan SP, Sarwer DB, Swain RM. Obese patients' perceptions of treatment outcomes and the factors that influence them. Arch Intern Med 2001;161:2133-2139.
76. Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol 1997;65:79-85.
77. Wadden T, Brownell K, Foster G. Obesity: responding to the global epidemic. J Consult Clin Psychol 2002;70:510-525.